<?xml version="1.1" encoding="utf-8"?>
<rdf:RDF xmlns:OMEXlib="http://omex-library.org/"
   xmlns:bqbiol="http://biomodels.net/biology-qualifiers/"
   xmlns:bqmodel="http://biomodels.net/model-qualifiers/"
   xmlns:dc="http://purl.org/dc/terms/"
   xmlns:foaf="http://xmlns.com/foaf/0.1/"
   xmlns:local="http://omex-library.org/NewOmex.omex/NewModel.rdf#"
   xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#">
  <rdf:Description rdf:about="http://omex-library.org/BIOMD0000000256.omex">
    <bqmodel:isDescribedBy rdf:resource="local:00001"/>
    <ns1:keyword xmlns:ns1="http://prismstandard.org/namespaces/basic/2.0/">Biomodels</ns1:keyword>
    <ns2:description xmlns:ns2="http://purl.org/dc/elements/1.1/">&lt;body xmlns="http://www.w3.org/1999/xhtml"&gt;
  &lt;p&gt;
          This is the &lt;em&gt;standard&lt;/em&gt; model described in the article:
          &lt;br/&gt;
  &lt;strong&gt;Systems analysis of effector caspase activation and its control by X-linked inhibitor of apoptosis protein.
          &lt;/strong&gt;
  &lt;br/&gt;
Rehm M, Huber HJ, Dussmann H, Prehn JH.
          &lt;em&gt;EMBO J.&lt;/em&gt; 2006 Sep 20;25(18):4338-49. Epub 2006 Aug 24.
          PMID:&lt;a href="http://www.ncbi.nlm.nih.gov/pubmed/16932741"&gt;16932741&lt;/a&gt;, doi:&lt;a href="http://dx.doi.org/10.1038/sj.emboj.7601295"&gt;10.1038/sj.emboj.7601295&lt;/a&gt;;
          &lt;br/&gt;
  &lt;strong&gt;Abstract:&lt;/strong&gt;
  &lt;br/&gt;
Activation of effector caspases is a final step during apoptosis. Single-cell imaging studies have demonstrated that this process may occur as a rapid, all-or-none response, triggering a complete substrate cleavage within 15 min. Based on biochemical data from HeLa cells, we have developed a computational model of apoptosome-dependent caspase activation that was sufficient to remodel the rapid kinetics of effector caspase activation observed in vivo. Sensitivity analyses predicted a critical role for caspase-3-dependent feedback signalling and the X-linked-inhibitor-of-apoptosis-protein (XIAP), but a less prominent role for the XIAP antagonist Smac. Single-cell experiments employing a caspase fluorescence resonance energy transfer substrate verified these model predictions qualitatively and quantitatively. XIAP was predicted to control this all-or-none response, with concentrations as high as 0.15 microM enabling, but concentrations &amp;gt;0.30 microM significantly blocking substrate cleavage. Overexpression of XIAP within these threshold concentrations produced cells showing slow effector caspase activation and submaximal substrate cleavage. Our study supports the hypothesis that high levels of XIAP control caspase activation and substrate cleavage, and may promote apoptosis resistance and sublethal caspase activation in vivo.
	&lt;/p&gt;
  &lt;p&gt;
This model is slightly altered from the description in the article. Cytochrome C and SMAC release from the mitochondrion is modelled as simple first order kinetics, giving the same form as the (integrated) equations in the supplement of the article. The apoptosome formation is modelled equally - and independent of the Cytochrome C release. The speed is either limited by the Apaf1 or ProCaspase9 concentration, whichever is higher, symbolised via the parameter with the ID &lt;em&gt;apolim&lt;/em&gt;.&lt;br/&gt;
Also, once the substrate concentration falls below 1 percent, the event &lt;em&gt;Production_Breakdown&lt;/em&gt; is triggered, leading to a breakdown of XIAP and procaspase3 production and turning off of the enhanced/proteosomal degradation (degradation rate for reactions 38,39,40,43,44,46,48,50,51 changes from 0.0347 to 0.0058).
  &lt;/p&gt;
  &lt;p&gt; Originally created by libAntimony v1.3 (using libSBML 3.4.1) &lt;/p&gt;
  &lt;p&gt;This model originates from BioModels Database: A Database of Annotated Published Models (http://www.ebi.ac.uk/biomodels/). It is copyright (c) 2005-2012 The BioModels.net Team.&lt;br/&gt;
For more information see the &lt;a href="http://www.ebi.ac.uk/biomodels/legal.html" target="_blank"&gt;terms of use&lt;/a&gt;.&lt;br/&gt;
To cite BioModels Database, please use: &lt;a href="http://www.ncbi.nlm.nih.gov/pubmed/20587024" target="_blank"&gt;Li C, Donizelli M, Rodriguez N, Dharuri H, Endler L, Chelliah V, Li L, He E, Henry A, Stefan MI, Snoep JL, Hucka M, Le Nov√®re N, Laibe C (2010) BioModels Database: An enhanced, curated and annotated resource for published quantitative kinetic models. BMC Syst Biol., 4:92.&lt;/a&gt;&lt;/p&gt;
&lt;/body&gt;</ns2:description>
    <ns3:title xmlns:ns3="http://purl.org/dc/elements/1.1/">Systems analysis of effector caspase activation and its control by X-linked inhibitor of apoptosis protein</ns3:title>
    <ns4:thumbnail xmlns:ns4="http://www.collex.org/schema#"
       rdf:resource="http://omex-library.org/BIOMD0000000256.omex/BIOMD0000000256.png"/>
    <ns5:thumbnail xmlns:ns5="http://www.collex.org/schema#"
       rdf:resource="http://omex-library.org/BIOMD0000000256.omex/curation_image.png"/>
  </rdf:Description>
  <rdf:Description rdf:about="local:00001">
    <ns6:identifier xmlns:ns6="http://purl.org/dc/elements/1.1/"
       rdf:resource="http://identifiers.org/doi/10.1038/sj.emboj.7601295"/>
    <ns7:label xmlns:ns7="http://www.w3.org/2000/01/rdf-schema#">Markus Rehm, Heinrich J Huber, Heiko Dussmann &amp; Jochen H M Prehn. Systems analysis of effector caspase activation and its control by X-linked inhibitor of apoptosis protein. The EMBO Journal 25, 18 (2006).</ns7:label>
  </rdf:Description>
</rdf:RDF>

